IoNIR Ridaforolimus-Eluting Coronary Stent System

ridaforolimus-eluting IoNIR coronary stent system · Medinol Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IoNIR Ridaforolimus-Eluting Coronary Stent System, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System [NA]